GILBERT WHITE

Summary

Affiliation: Blood Research Institute
Country: USA

Publications

  1. doi request reprint Current status of thrombolytics-the need for better, especially safer, agents
    Gilbert C White
    BloodCenter of Wisconsin, Milwaukee, WI, USA
    Thromb Res 122:S1-2. 2008
  2. ncbi request reprint Platelet secretion: indiscriminately spewed forth or highly orchestrated?
    G C White
    Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201 2178, USA
    J Thromb Haemost 5:2006-8. 2007
  3. ncbi request reprint Parachutes and prophylaxis: they both work!
    G C White
    Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201 2178, USA
    J Thromb Haemost 4:1226-7. 2006
  4. ncbi request reprint Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII
    D A Wilcox
    Department of Pediatrics, Medical College of Wisconsin, and Children s Hospital of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Thromb Haemost 1:2477-89. 2003
  5. ncbi request reprint Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
    G C White
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin 53226 3548, USA
    J Thromb Haemost 3:1676-81. 2005
  6. ncbi request reprint Gene therapy for hemophilia?
    G C White
    J Thromb Haemost 3:1312. 2005
  7. ncbi request reprint B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study
    C M Kessler
    Georgetown University Medical Center, Washington, DC 20007 2197, USA
    Haemophilia 11:84-91. 2005
  8. ncbi request reprint Cranial pseudotumour in haemophilia
    E N Libby
    Department of Internal Medicine, University of New Mexico Hospital, Albuquerque, NM 87131, USA
    Haemophilia 10:186-8. 2004
  9. ncbi request reprint The partial thromboplastin time: defining an era in coagulation
    G C White
    Division of Hematology Oncology, Center for Thrombosis and Hemostasis, Chapel Hill, NC 27599, USA
    J Thromb Haemost 1:2267-70. 2003
  10. ncbi request reprint Use of recombinant factor IX in subjects with haemophilia B undergoing surgery
    M V Ragni
    University of Pittsburgh School of Medicine, General Clinical Research Center, Hemophilia Center of Western Pennsylvania, Pittsburgh 15213, USA
    Haemophilia 8:91-7. 2002

Research Grants

Collaborators

Detail Information

Publications13

  1. doi request reprint Current status of thrombolytics-the need for better, especially safer, agents
    Gilbert C White
    BloodCenter of Wisconsin, Milwaukee, WI, USA
    Thromb Res 122:S1-2. 2008
    ..This supplement reviews the role of plasmin in fibrinolysis and locally administered plasmin as a safe and effective therapeutic...
  2. ncbi request reprint Platelet secretion: indiscriminately spewed forth or highly orchestrated?
    G C White
    Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201 2178, USA
    J Thromb Haemost 5:2006-8. 2007
  3. ncbi request reprint Parachutes and prophylaxis: they both work!
    G C White
    Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201 2178, USA
    J Thromb Haemost 4:1226-7. 2006
  4. ncbi request reprint Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII
    D A Wilcox
    Department of Pediatrics, Medical College of Wisconsin, and Children s Hospital of Wisconsin, Milwaukee, Wisconsin 53226, USA
    J Thromb Haemost 1:2477-89. 2003
    ..These results suggest feasibility for the development of a locally inducible secretory pool of FVIII in platelets of patients with hemophilia A...
  5. ncbi request reprint Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs?
    G C White
    Blood Research Institute, BloodCenter of Wisconsin, Milwaukee, Wisconsin 53226 3548, USA
    J Thromb Haemost 3:1676-81. 2005
    ..The interplay of these two variables in the context of why some but not all hemophiliacs develop antibodies after treatment with replacement factor is reviewed...
  6. ncbi request reprint Gene therapy for hemophilia?
    G C White
    J Thromb Haemost 3:1312. 2005
  7. ncbi request reprint B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study
    C M Kessler
    Georgetown University Medical Center, Washington, DC 20007 2197, USA
    Haemophilia 11:84-91. 2005
    ..BDDrFVIII (ReFacto) has been developed with the additional benefit of being formulated without human albumin...
  8. ncbi request reprint Cranial pseudotumour in haemophilia
    E N Libby
    Department of Internal Medicine, University of New Mexico Hospital, Albuquerque, NM 87131, USA
    Haemophilia 10:186-8. 2004
    ..Intracranial pseudotumour has rarely been reported in haemophilia. We present the fourth case describing this complication...
  9. ncbi request reprint The partial thromboplastin time: defining an era in coagulation
    G C White
    Division of Hematology Oncology, Center for Thrombosis and Hemostasis, Chapel Hill, NC 27599, USA
    J Thromb Haemost 1:2267-70. 2003
  10. ncbi request reprint Use of recombinant factor IX in subjects with haemophilia B undergoing surgery
    M V Ragni
    University of Pittsburgh School of Medicine, General Clinical Research Center, Hemophilia Center of Western Pennsylvania, Pittsburgh 15213, USA
    Haemophilia 8:91-7. 2002
    ..Thus, rFIX was found to be safe and effective in achieving haemostasis in subjects with FIX deficiency undergoing surgery...
  11. ncbi request reprint Characterization of high-risk HIV-1 seronegative hemophiliacs
    J R Salkowitz
    Division of Infectious Diseases, Case Western Reserve University, Cleveland, Ohio, 44106, USA
    Clin Immunol 98:200-11. 2001
    ..Thus alloreactivity may predispose to acquisition of HIV-1 infection after parenteral exposure...
  12. ncbi request reprint ERGIC-53 gene structure and mutation analysis in 19 combined factors V and VIII deficiency families
    W C Nichols
    Division of Human Genetics, Children s Hospital Medical Center, Cincinnati, OH, USA
    Blood 93:2261-6. 1999
    ..Taken together, these results suggest that a significant subset of combined factors V and VIII deficiency is due to mutation in one or more additional genes...
  13. ncbi request reprint Factor VIII gene and hemophilia A
    G C White
    Department of Medicine, University of North Carolina, Chapel Hill 27599
    Blood 73:1-12. 1989

Research Grants1

  1. Role of Carboxyterminal Hypervariable Region in Rap1b Function
    Gilbert C White; Fiscal Year: 2010
    ..These findings will provide insight into how the body heals bleeding injuries, as well as the underlying cause of blood clotting conditions. ..